Here, we demonstrate that in IPF lung fibroblasts, DMF treatment inhibited both TGF-β-mediated pro-fibrotic phenotypes and led to a reversal of established pro-fibrotic phenotypes. This evidence concerns the gene TGFB1 and idiopathic pulmonary fibrosis.